Insider Transactions in Q4 2021 at Schrodinger, Inc. (SDGR)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2021
|
Robert Lorne Abel Officer |
SELL
Open market or private sale
|
Direct |
15,601
-93.91%
|
$561,636
$36.54 P/Share
|
|
Dec 13
2021
|
Robert Lorne Abel Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,601
+50.0%
|
$265,217
$17.0 P/Share
|
|
Oct 15
2021
|
Karen Akinsanya President of R&D, Therapeutics |
SELL
Open market or private sale
|
Direct |
1,393
-100.0%
|
$76,615
$55.75 P/Share
|
|
Oct 15
2021
|
Karen Akinsanya President of R&D, Therapeutics |
BUY
Exercise of conversion of derivative security
|
Direct |
1,393
+50.0%
|
$5,572
$4.34 P/Share
|